000			01396 a2200385 4500
005			20250514192318.0
264		0	_c20050315
008			200503s 0 0 eng d
022			_a0378-5122
024	7		_a10.1016/j.maturitas.2003.12.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aKendler, David
245	0	0	_aPatients with osteoporosis prefer once weekly to once daily dosing with alendronate. _h[electronic resource]
260			_bMaturitas _cJul 2004
300			_a243-51 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAlendronate _xadministration & dosage
650	0	4	_aCross-Over Studies
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aOsteoporosis, Postmenopausal _xdrug therapy
650	0	4	_aPatient Satisfaction
650	0	4	_aSurveys and Questionnaires
700	1		_aKung, Annie Wai Chee
700	1		_aFuleihan, Ghada El-Hajj
700	1		_aGonzález González, José Gerardo
700	1		_aGaines, Keavy A
700	1		_aVerbruggen, Nadia
700	1		_aMelton, Mary E
773	0		_tMaturitas _gvol. 48 _gno. 3 _gp. 243-51
856	4	0	_uhttps://doi.org/10.1016/j.maturitas.2003.12.012 _zAvailable from publisher's website
999			_c14913421 _d14913421